2015长城会:胡大一:弥合裂痕,打造健康4S店

2015-10-31 MedSci MedSci原创

“前几天我在高铁上抢救的那位患者,才40多岁,已经装了两个支架,术后还不按照医嘱吃药,所以又发生了急性心梗。如果他的身体也能得到像汽车4S店那样的保养,那么就不至于年纪轻轻就到了屡次大修的地步”。胡大一教授在今天上午的报告中,提起前几天高铁上他抢救的那位患者,仍然心痛不已。今年长城会的主题是“弥合裂痕,应对挑战”。对此,胡大一教授解释道:“所谓弥合裂痕,就是要弥合公共卫生/预防医学与临床医学的

“前几天我在高铁上抢救的那位患者,才40多岁,已经装了两个支架,术后还不按照医嘱吃药,所以又发生了急性心梗。如果他的身体也能得到像汽车4S店那样的保养,那么就不至于年纪轻轻就到了屡次大修的地步”。胡大一教授在今天上午的报告中,提起前几天高铁上他抢救的那位患者,仍然心痛不已。

今年长城会的主题是“弥合裂痕,应对挑战”。对此,胡大一教授解释道:“所谓弥合裂痕,就是要弥合公共卫生/预防医学与临床医学的裂痕;应对挑战,是指应对非传染性疾病(NCD)的严峻挑战。”

胡教授首先分析了产生“裂痕”的原因。他指出,我们国家过去学习前苏联的防疫站体系,近年又学习美国的疾病控制中心体系,这都是在面对传染病威胁时,把公共卫生/预防医学与临床医学分离; 面临非传染性疾病的挑战,防与治的“裂痕”日益加深,弊病日益凸显。

胡教授指出,非传染性疾病/动脉粥样硬化性心血管疾病是生活方式病,所以生活方式治疗是一级预防的基石,也是二级预防的基础。然而我们现在的局面是:医院坐堂行医,等人得病,前不防,后不管,得了心肌梗死救治晚,攀比毛收入,局限于高成本生物技术——药片、支架、手术刀、机器人,不重视、不会也不用生活方式治疗措施;公共卫生/预防医学领域有大量生活方式治疗的研究成果、技术、证据、指南,却无法用于临床医学,实现其价值;医疗保险仅支付生物技术费用,未形成生活方式治疗的保险付费机制,心肺肾为代表的脏器康复服务属二级预防,毫无医保支持。这就是裂痕所在。

如何弥合这个“裂痕”?如何架起健康教育和行为改变的桥梁?如何将生活方式治疗融入临床实践?胡教授认为,这就需要颠覆医疗。需要对医学体系进行“颠覆性创新”,进行新的变革。颠覆包括三个方面:医学目的、医学模式、医疗健康服务体系。

胡教授指出,医学的目的是预防疾病,促进健康。用世界卫生组织一份报告中的话说:“错误的医学目的必然导致医学知识和技术的误用。”所以,他认为,应该把医学发展的优先战略从“以治愈疾病为目的的高技术追求”,转向“预防疾病和损伤,维持和促进健康”,只有以“预防疾病,促进健康”为首要目的的医学才是供得起、可持续的医学,才是公平和公正的医学。

胡教授说的第二个颠覆是医学模式的转变。他认为,现代医学“颠覆创新”的根本出路是从单纯的生物医学模式转成社会--生物--心理模式。他指出,单纯生物模式在征服传染病的过程中获得了巨大成就,非常令人兴奋,这是因为传染病的发病规律是病源单一、因果关系明确、有明确传播途径,所以防控途径依靠抗菌或抗病毒药物、疫苗、隔离。但是这种单纯的生物医学模式面对非传染性疾病的挑战是非常无奈和苍白的。因为非传染性疾病发病规律是由不健康社会环境和不健康生活方式、行为等多重危险因素导致,所以它的防护途径主要是通过健康促进、健康教育,来改变社会环境,改变生活方式。

最后,胡教授提到了第三个颠覆,即医疗健康服务体系的颠覆。他指出,现在的医疗机构是“断裂”的碎片式体系,是“铁路警察,各管一段”,“前缺防,后缺管,得了心梗救治晚”。因此他认为支架、搭桥是姑息治疗,治标不治本,应该建立一体化健康服务体系,好比汽车的“4S”店。胡教授表示,心肺肾三个脏器面对三个人群:高危人群、肥胖的人需要健康管理;患病人群需要康复,预防疾病复发;老年群体,需要医养结合;这三个人群都需要五个处方,即药物、运动、营养、心理(含睡眠管理)和戒烟限酒。

胡教授展示了2014年北京疾控中心报告的数字:男性期望寿命80.22岁,但是健康期望寿命只有61.40岁;男性期望寿命84.50岁,但是健康期望寿命只有62.06岁。这说明我们有20年处于非健康状态,是带病生存。这种带病生存会给社会带来巨大的负担。胡教授以美国为例,说明了医疗服务体系的改变,使得更多的患者减少了急性发作,减少了医疗资源的占用,从而也就控制了成本。他指出,心血管医学发展转型的要点是:V2V,从盲目增加医院规模、病床数量转向医学的价值职能;Q2Q,从病人数量、介入手术数量转向医疗质量和医疗安全;I2P,从干预转向预防。

胡教授指出,要探索心肺肾为代表的脏器康复中国梦、中国路,大办慢病管理的4S店,落实五个处方药物、运动、营养、心理(含睡眠管理)和戒烟限酒,以患者为中心,以全新团队为基础的全面全程管理、服务、关爱模式,包括临床医生领导下的护士、运动治疗师、营养师、心理治疗师、社工和志愿者、患者家庭成员;建立整合化一的平台,对CVD患者提供全面、全程医疗管理、关爱和服务,最大程度减少心血管疾病对身心的不良影响,降低猝死或再梗死的危险、控制心脏症状、稳定和逆转动脉粥样硬化斑块,改善心理社会和职业状态,最重要的是通过对患者的管理,提高患者自我管理能力,提高患者话语权和参与决策的能力。

胡教授认为,要实现这些新理念、新实践,需要各方联动,形成合力。这其中包括民营资本投资、二级医疗机构、体检中心、综合性医院、大学附属医院等。

胡教授认为,当前的政策也给了我们以机遇。如:促进康体结合,加强体育运动指导,推广“运动处方”,发挥体育锻炼在疾病防治以及健康促进等方面的积极作用;大力发展运动医学和康复医学,积极研发运动康复技术;鼓励社会资本开办康体、体质测定和运动康复等各类机构。

胡教授总结道,通过心脏康复/二级预防的整合医学模式,架起健康教育和行为改变的桥梁,把碎片式的医疗模式转变为覆盖生命全程的系统化医疗保健体系,将有助于弥合防与治的裂痕,实现非传染性疾病/动脉粥样硬化性心血管疾病前防后管、防治康养,使得医学回归人文,推动医患和谐。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    中国人太多

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    医疗资源平均还是缺少

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    好理念

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-01 nizongzan

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-01 1dde8dabm02(暂无匿称)

    好理念

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-01 pharmxing

    有道理。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-01 糖果鱼塘

    认识到这一点很可贵,就看有多少人这样走了!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=42292, encodeId=9f844229267, content=中国人太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42293, encodeId=677442293be, content=医疗资源平均还是缺少, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:57:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42291, encodeId=f60d4229182, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 14:56:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322729, encodeId=e7a81322e2964, content=<a href='/topic/show?id=355b96891fe' target=_blank style='color:#2F92EE;'>#长城会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96891, encryptionId=355b96891fe, topicName=长城会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef33504, createdName=wsusan1966, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394800, encodeId=bcfd139480053, content=<a href='/topic/show?id=94bb83e90b7' target=_blank style='color:#2F92EE;'>#胡大一#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83790, encryptionId=94bb83e90b7, topicName=胡大一)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eeb2500172, createdName=haouestc, createdTime=Mon Nov 02 13:54:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42164, encodeId=f9ab4216450, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Sun Nov 01 22:11:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42133, encodeId=96e742133cb, content=好理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd41660123, createdName=1dde8dabm02(暂无匿称), createdTime=Sun Nov 01 13:18:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42120, encodeId=57924212099, content=有道理。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 11:00:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42110, encodeId=1e0e421109f, content=认识到这一点很可贵,就看有多少人这样走了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Sun Nov 01 07:54:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42109, encodeId=4ae54210912, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Nov 01 06:43:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2015-11-01 三三五五

    0

相关资讯

BMJ Open:男性易发生不稳定型心绞痛

不稳定型心绞痛,是介于劳累性稳定型心绞痛与急性心肌梗死和猝死之间的临床表现。主要包括初发心绞痛、恶化劳力性心绞痛、静息心绞痛伴心电图缺血改变和心肌梗死后早期心绞痛。其特征是心绞痛症状进行性增加,新发作的休息或夜间性心绞痛或出现心绞痛持续时间延长。研究者在芬兰进行了一项基于人群的回顾性研究,探究因不稳定型心绞痛(UAP)的住院率的性别差异和年龄差异。该研究纳入了2000年5月-2009年10月间、≥

FDA:批准恩他卡朋辅助治疗帕金森病

近日,FDA的审查结果表明,没有明确证据表明使用恩他卡朋(一种用于治疗帕金森病的药物)会增加民众患心肌梗死、中风和其他心血管疾病的患病几率。因此,FDA在新闻发布会上解释道,恩他卡朋可作为标准药物左旋多巴/苄丝肼或左旋多巴/卡比多巴的辅助用药,用于治疗以上药物不能控制的帕金森病及剂末现象(症状波动)。 此前,由于目前卡比多巴和左旋多巴已被广泛使用来治疗帕金森病,但并没有任何证据证明其有增加心血管疾

第二十六届长城国际心脏病学会议隆重开幕 MedSci参展

2015年10月30日,第二十六届长城国际心脏病学会议暨第九届北京五洲国际心血管病会议、亚太心脏大会和国际心血管病预防与康复会议2015在中国北京国家会议中心隆重开幕。 以心血管疾病为首的慢病危机正在全球蔓延,我国的心血管疾病发病人数不断增加并呈现年轻化趋势,心血管疾病的防控面临严峻挑战。预防和治疗、疾病预防控制和医院医疗两大体系的裂痕日益加深,公共卫生和预防医学领域大量研究成果和技术等

高铁救人心血管专家胡大一:坚持11年的健康良方

最近,我国著名的心血管专家胡大一火了!昨天中午,G672次列车15号车厢的李翔突发心肌梗死,正巧车上遇到我国著名的心血管专家胡大一,在他的指导下,病人被送往河南省人民医院,最后恢复正常。大家都在盛赞这位名医有仁心!下面,为大家更多普及这位有好医术、仁心专家的健康良方! 胡大一是国家人事部和北京市突出贡献专家,享受政府特殊津贴。毕业于北京医学院,在美国纽约州立大学医学院和芝加哥伊利诺大学医

Diabetes Care:大剂量胰岛素会不会增加心血管疾病死亡风险?

ACCORD试验指出对2型糖尿病患者进行强化治疗,以及高的心血管疾病风险,会导致各种病因以及心血管疾病死亡风险的增加。而血糖快速降低、低血糖或者特殊药物对心血管疾病死亡率的影响仍不明确。研究者进行了一项研究探究胰岛素剂量是否会增加心血管疾病死亡风险。该研究纳入了10163名参与者,平均随访5年。通过Cox风险比例模型计算两者间HR值。研究中强化治疗(79%)比标准治疗(62%)每日胰岛素用量更多

Am J Clin Nutr:WHO推荐的饮食指南能不能降低心血管疾病死亡率?

全球范围内心血管疾病(CVD)是导致死亡的头号凶手,尤其是对于老年人。因此只有对针对老年人制定好CVD预防策略才可以有效减少CVD发生率。研究者进行了一项研究,探究WHO的膳食推荐与年龄≥60岁的老年人CVD、冠状动脉疾病(CAD)以及卒死亡率间的关系。该研究包含了来自欧洲和美国的共计10项前瞻性研究,共纳入了 281,874名没有慢性基础疾病的男男女女。健康的饮食指标 (HDI) 包括饱和脂肪酸